Get started
Author

Samuel Ellis

Observed name: Samuel J. Ellis
ORCID: 0000-0002-5012-4277
Observed ORCID: 0000-0002-5012-4277
OpenAlex ID: A5084617443
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
2024 · Rik G. H. Lindeboom, Kaylee B. Worlock, et al. · Nature · 151
Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors
2017 · Massiel Cepeda-Molero, Cedric N. Berger, et al. · PLoS Pathogens · 80
PDF
Age-specific nasal epithelial responses to SARS-CoV-2 infection
2024 · Maximillian N. J. Woodall, Ana-Maria Cujba, et al. · Nature Microbiology · 62
PDF
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
2024 · Joseph F. Standing, Laura Buggiotti, et al. · Nature Communications · 44
PDF
Identification and characterisation of enteroaggregative Escherichia coli subtypes associated with human disease
2020 · Samuel J. Ellis, Lisa C. Crossman, et al. · Scientific Reports · 40
PDF
Flagellin Induces β-Defensin 2 in Human Colonic Ex vivo Infection with Enterohemorrhagic Escherichia coli
2016 · Steven B. Lewis, Alison Prior, et al. · Frontiers in Cellular and Infection Microbiology · 28
PDF
Efficient in vitro assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains
2024 · Maximillian Woodall, Samuel Ellis, et al. · Antimicrobial Agents and Chemotherapy · 13
Oxygen and contact with human intestinal epithelium independently stimulate virulence gene expression in enteroaggregative Escherichia coli
2019 · Samuel J. Ellis, Muhammad Yasir, et al. · Cellular Microbiology · 9
PDF
Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients
2023 · Samuel Ellis, Rosie Way, et al. · Mucosal Immunology · 8
Trypanotoxic activity of thiosemicarbazone iron chelators
2015 · Samuel Ellis, Darren W. Sexton, et al. · Experimental Parasitology · 8
PDF
Donor-derived airway air–liquid interface model for high-throughput screening of antiviral combinations with concurrent analysis of antiviral efficacy and epithelial toxicity using ciliR
2026 · Daniela Cardinale, Oriane Grant, et al. · ERJ Open Research · 4
A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration
2025 · Bach Tran Nguyen, Julie Bertrand, et al. · The Journal of Infectious Diseases · 4
PDF
Nirmatrelvir–ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022–23: virological and immunological results of an open-label randomised trial (PANORAMIC)
2026 · David M Lowe, Shengyuan Zhang, et al. · The Lancet Microbe · 3
PDF
Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
2024 · Rik G. H. Lindeboom, Kaylee B. Worlock, et al. · Nature · 3
PDF
Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection
2026 · Samuel Ellis, Amy I. Jacobs, et al. · npj Antimicrobials and Resistance · 2
PDF
Neutrophil myeloperoxidase as a functional biomarker for RSV severity: implications for in vitro therapeutic screening
2026 · Machaela Palor, Tereza Masonou, et al. · Nature Communications · 1
PDF
Author Correction: Age-specific nasal epithelial responses to SARS-CoV-2 infection
2024 · Maximillian N. J. Woodall, Ana-Maria Cujba, et al. · Nature Microbiology · 1
Design and development of a SARS and MERS Combination Vaccine
2025 · Antonio Casal, Mohamed D. Yousif, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Human SARS-CoV-2 challenge uncovers differences in local and systemic cellular responses associated with protection from infection and distinct infection states
2024 · Kaylee Worlock, Rik G.H. Lindeboom, et al. · European Respiratory Journal
Longevity and neutralisation activity of secretory IgA following SARS-CoV-2 infection
2022 · Samuel Ellis, Alice Burleigh, et al. · Access Microbiology
Investigating enteroaggregative Escherichia coli virulence factors in human intestinal infection
2018 · Samuel Ellis · UEA Digital Repository (University of East Anglia)
PDF
Works count: 21
Citation count: 461
H-index: 8
I10-index: 7
Year
Topic
Type